164 related articles for article (PubMed ID: 31563899)
1. Cold Atmospheric Plasma Disarms M1 Protein, an Important Streptococcal Virulence Factor.
Persson ST; Ekström S; Papareddy P; Herwald H
J Innate Immun; 2020; 12(4):277-290. PubMed ID: 31563899
[TBL] [Abstract][Full Text] [Related]
2. Soluble M1 protein of Streptococcus pyogenes triggers potent T cell activation.
Påhlman LI; Olin AI; Darenberg J; Mörgelin M; Kotb M; Herwald H; Norrby-Teglund A
Cell Microbiol; 2008 Feb; 10(2):404-14. PubMed ID: 17900297
[TBL] [Abstract][Full Text] [Related]
3. Leucocyte recruitment and molecular fortification of keratinocytes triggered by streptococcal M1 protein.
Persson ST; Hauri S; Malmström J; Herwald H
Cell Microbiol; 2018 Jan; 20(1):. PubMed ID: 28973822
[TBL] [Abstract][Full Text] [Related]
4. Vigilant keratinocytes trigger pathogen-associated molecular pattern signaling in response to streptococcal M1 protein.
Persson ST; Wilk L; Mörgelin M; Herwald H
Infect Immun; 2015 Dec; 83(12):4673-81. PubMed ID: 26416902
[TBL] [Abstract][Full Text] [Related]
5. Human IgG Increases Virulence of
Ermert D; Weckel A; Magda M; Mörgelin M; Shaughnessy J; Rice PA; Björck L; Ram S; Blom AM
J Immunol; 2018 May; 200(10):3495-3505. PubMed ID: 29626087
[No Abstract] [Full Text] [Related]
6. The quest for GAS vaccine.
Pandey M; Good MF
Oncotarget; 2015 Oct; 6(33):34063-4. PubMed ID: 26485764
[No Abstract] [Full Text] [Related]
7. Status of research and development of vaccines for Streptococcus pyogenes.
Steer AC; Carapetis JR; Dale JB; Fraser JD; Good MF; Guilherme L; Moreland NJ; Mulholland EK; Schodel F; Smeesters PR
Vaccine; 2016 Jun; 34(26):2953-2958. PubMed ID: 27032515
[TBL] [Abstract][Full Text] [Related]
8. Antibodies against a surface protein of Streptococcus pyogenes promote a pathological inflammatory response.
Kahn F; Mörgelin M; Shannon O; Norrby-Teglund A; Herwald H; Olin AI; Björck L
PLoS Pathog; 2008 Sep; 4(9):e1000149. PubMed ID: 18787689
[TBL] [Abstract][Full Text] [Related]
9. Development of Phage-Based Antibody Fragment Reagents for Affinity Enrichment of Bacterial Immunoglobulin G Binding Proteins.
Säll A; Sjöholm K; Waldemarson S; Happonen L; Karlsson C; Persson H; Malmström J
J Proteome Res; 2015 Nov; 14(11):4704-13. PubMed ID: 26452057
[TBL] [Abstract][Full Text] [Related]
10. [Distribution of emm genotypes and antibiotic susceptibility of Streptococcus pyogenes strains: analogy with the vaccine in development].
Arslan U; Oryaşın E; Eskin Z; Türk Dağı H; Fındık D; Tuncer I; Bozdoğan B
Mikrobiyol Bul; 2013 Apr; 47(2):318-23. PubMed ID: 23621731
[TBL] [Abstract][Full Text] [Related]
11. Sequence variability is correlated with weak immunogenicity in Streptococcus pyogenes M protein.
Lannergård J; Kristensen BM; Gustafsson MC; Persson JJ; Norrby-Teglund A; Stålhammar-Carlemalm M; Lindahl G
Microbiologyopen; 2015 Oct; 4(5):774-89. PubMed ID: 26175306
[TBL] [Abstract][Full Text] [Related]
12. Group A streptococcus epidemiology and vaccine implications.
Cohen-Poradosu R; Kasper DL
Clin Infect Dis; 2007 Oct; 45(7):863-5. PubMed ID: 17806050
[No Abstract] [Full Text] [Related]
13. Combinatorial Synthetic Peptide Vaccine Strategy Protects against Hypervirulent CovR/S Mutant Streptococci.
Pandey M; Mortensen R; Calcutt A; Powell J; Batzloff MR; Dietrich J; Good MF
J Immunol; 2016 Apr; 196(8):3364-74. PubMed ID: 26969753
[TBL] [Abstract][Full Text] [Related]
14. Host-microbe interactions in the pathogenesis of invasive group A streptococcal infections.
The Editors
J Med Microbiol; 2000 Oct; 49(10):849-852. PubMed ID: 11023181
[No Abstract] [Full Text] [Related]
15. Protein H, an antiphagocytic surface protein in Streptococcus pyogenes.
Kihlberg BM; Collin M; Olsén A; Björck L
Infect Immun; 1999 Apr; 67(4):1708-14. PubMed ID: 10085008
[TBL] [Abstract][Full Text] [Related]
16. Don't forget about Streptococcus pyogenes! (comment on Microbes Infect. 5 (2003) 1329-1335).
Collin M
Microbes Infect; 2004 Mar; 6(3):336; author reply 337. PubMed ID: 15026018
[No Abstract] [Full Text] [Related]
17. SCM, the M Protein of
Bergmann S; Eichhorn I; Kohler TP; Hammerschmidt S; Goldmann O; Rohde M; Fulde M
Front Cell Infect Microbiol; 2017; 7():80. PubMed ID: 28401063
[TBL] [Abstract][Full Text] [Related]
18. Prospects for a group A streptococcal vaccine.
McMillan DJ; Chhatwal GS
Curr Opin Mol Ther; 2005 Feb; 7(1):11-6. PubMed ID: 15732524
[TBL] [Abstract][Full Text] [Related]
19. Molecular epidemiology and virulence characteristics of prevalent group A streptococci recovered from patients in northern India.
Arya DK; Sharma A; Mehta G; Dua M; Johri AK
J Infect Dev Ctries; 2014 Mar; 8(3):271-81. PubMed ID: 24619256
[TBL] [Abstract][Full Text] [Related]
20. Human kininogens interact with M protein, a bacterial surface protein and virulence determinant.
Ben Nasr AB; Herwald H; Müller-Esterl W; Björck L
Biochem J; 1995 Jan; 305 ( Pt 1)(Pt 1):173-80. PubMed ID: 7826326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
